rapporteur Sabine Klepsch
3 IP cases indexed. Covers patent matters.
Cases Presided Over
3 cases indexed | Page 1 of 1
Samsung Bioepis NL B.V. v.Respondent
This is a cost decision by the Local Division Hamburg of the Unified Patent Court following the dismissal of Alexion Pharmaceuticals' application for provisional measures against Samsung Bioepis's marketing of Epysqli®. Samsung Bioepis sought reimbursement of its legal costs, and the court partially granted the application, recognizing costs for two legal representatives, two patent attorneys, and an expert, but rejecting costs for two English solicitors as not sufficiently justified.
Samsung Bioepis NL B.V. v.Alexion Pharmaceuticals, Inc.
This case concerns a cost decision for appeal proceedings before the Unified Patent Court, Local Division Hamburg, relating to European Patent EP 3 167 888 B1. Alexion Pharmaceuticals, the patent proprietor, had its application for provisional measures against Samsung Bioepis's product Epysqli® dismissed at first instance and on appeal, with costs ordered against it. Samsung Bioepis sought reimbursement of its appeal costs, and the court partially granted the application, finding that costs for two legal representatives and four patent attorneys were largely reasonable, but disallowing costs for two English solicitors and certain travel expenses.
Tandem Diabetes Care, Inc., Tandem Diabetes Care Europe B.V., v.Respondent
1 Hamburg – Local Division UPC_CFI_88/2024 Preliminary Order of the Court of First Instance of the Unified Patent Court Issued: 09/09/2024 PARTIES: Roche Diabetes Care GmbH, represented by Herrn Götzl, Sandhofer Straße 116, 68305 Mannheim, Germany, Plaintiff and Counterdefendant 1
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.